Cardionomic
Total Raised
$50MInvestors Count
5Deal Terms
2Funding, Valuation & Revenue
4 Fundings
Cardionomic has raised $50M over 4 rounds.
Cardionomic's latest funding round was a Debt for $5M on October 4, 2021.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/4/2021 | Debt | $5M | Undisclosed Investors | 1 | ||
2/21/2020 | Series C | |||||
4/30/2018 | Series B | |||||
10/16/2015 | Series A |
Date | 10/4/2021 | 2/21/2020 | 4/30/2018 | 10/16/2015 |
|---|---|---|---|---|
Round | Debt | Series C | Series B | Series A |
Amount | $5M | |||
Investors | Undisclosed Investors | |||
Valuation | ||||
Revenue | ||||
Sources | 1 |
Cardionomic Deal Terms
2 Deal Terms
Cardionomic's deal structure is available for 2 funding rounds, including their Series B from April 30, 2018.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Cardionomic Investors
5 Investors
Cardionomic has 5 investors. NEA invested in Cardionomic's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/16/2015 | 2/21/2020 | 2 Series A, Series C (2020) | Venture Capital | California | ||
Corporate Venture | Missouri | |||||
Venture Capital | United Kingdom | |||||
Corporation | Texas | |||||
Corporate Venture | Ohio |
First funding | 10/16/2015 | ||||
|---|---|---|---|---|---|
Last Funding | 2/21/2020 | ||||
Investor | |||||
Rounds | 2 Series A, Series C (2020) | ||||
Board Seats | |||||
Type | Venture Capital | Corporate Venture | Venture Capital | Corporation | Corporate Venture |
Location | California | Missouri | United Kingdom | Texas | Ohio |
Loading...